Chapter 31
Pathophysiology of Skeletal Muscle Ischemia-reperfusion Injury
Walter N. Durán,
Peter J. Pappas,
Mauricio P. Boric,
Robert W. Hobson II,
Walter N. Durán
Search for more papers by this authorPeter J. Pappas
Search for more papers by this authorMauricio P. Boric
Search for more papers by this authorRobert W. Hobson II
Search for more papers by this authorWalter N. Durán,
Peter J. Pappas,
Mauricio P. Boric,
Robert W. Hobson II,
Walter N. Durán
Search for more papers by this authorPeter J. Pappas
Search for more papers by this authorMauricio P. Boric
Search for more papers by this authorRobert W. Hobson II
Search for more papers by this authorBook Editor(s):Enrico Ascher,
L. H. Hollier,
D. Eugene Strandness,
Jonathan B. Towne,
Keith Calligaro,
K. Craig Kent,
Gregory L. Moneta,
William H. Pearce,
John J. Ricotta,
Henry Haimovici,
Enrico Ascher
Search for more papers by this authorL. H. Hollier
Search for more papers by this authorD. Eugene Strandness
Search for more papers by this authorJonathan B. Towne
Search for more papers by this authorKeith Calligaro
Search for more papers by this authorK. Craig Kent
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorWilliam H. Pearce
Search for more papers by this authorJohn J. Ricotta
Search for more papers by this authorHenry Haimovici
Search for more papers by this authorSummary
This chapter contains section titled:
-
Pathophysiology of Skeletal Muscle Ischemia—Reperfusion Injury
-
Role of the Endothelium
-
Role of the Neutrophil
-
Endothelial Cell—Leukocyte Interactions
-
Chemical Mediators and Signaling Molecules
-
Clinical Recommendations and Future Directions
References
- Fogarty TJ, Cranley JJ et al. A method for extraction of arterial emboli and thrombi. Surg Gynecol Obstet 1963; 116: 241.
- Blaisdell FW, Steele M, Allen RE. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surg 1978; 84: 822.
- Glick D, Grundest WS. Intraoperative decisions based on angioscopy. Circulation 1988; 78 (Suppl 1, No. 3): 13.
- Cohen LH, Kaplan M. Bernhard, VM. Intraoperative streptokinase: An adjunct to mechanical thrombectomy in the management of acute ischemia. Arch Surg 1986; 121: 708.
- Haimovici H. Peripheral arterial embolism. A study of 330 unselected cases of embolism to the extremities. Angiology 1950; 1: 20.
- Thompson JE, Sigler L, et al. Arterial embolectomy: A 2-year experience with 163 cases. Surgery 1970; 67: 212.
- Thompson JE, Weston AS, Sigler L. Arterial embolectomy after acute myocardial infarction: A study of 31 patients. Ann Surg 1970; 171: 979.
- Satiani B, Evans WE. Immediate prognosis and five-year survival after arterial embolectomy following myocardial infarction. Surg Gynecol Obstet 1980; 150: 41.
- Lusby RJ, Wylie EJ. Acute lower extremity ischemia: Pathogenesis and management. Word J Surg 1983; 7: 340.
- Blaisdell FW. The reperfusion syndrome. Microcirc Endothelium Lymphatics 1989; 5: 127.
- Harris K, Walker P, et al. Metabolic response of skeletal muscle to ischemia. Am J Physiol 1986; 250 (19): H213–H220.
- Suval WD, Hobson RW II, et al. Assessment of ischemia reperfusion injury in skeletal muscle by macromolecular clearance. J Surg Res 1987; 42: 550–559.
- Suval WD, Durán WN, et al. Microvascular transport and endothelial cell alternations precede skeletal muscle damage in ischemia-reperfusion injury. Am J Surg 1987; 154: 211–218.
- McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159.
- Granger DN, McCord JM, et al. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology 1986; 90: 80.
- Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988; 255: H1269.
- Del Maestro RF. An approach to free radicals in medicine and biology. Acta Physiol Scand 1980; 492 (Suppl): 153.
- Halliwell B, Gutterridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1.
- Durán WN, Dillon PK. Effects of ischemia-reperfusion injury on microvascular permeability in skeletal muscle. Microcirc Endothelium Lymphatics 1989; 5: 223–239.
- Wright JG. Pharmacological and nonpharmacological methods for preservation of skeletal muscle viability; mechanisms and potential clinical applications. Semin Vasc Surg 1992; 5 (1): 28–41.
- Jarasch ED, Grund C, et al. Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell 1981; 25: 67.
- Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine; a re-evaluation. Am J Physiol 1988; 254: G768.
- Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1.
- Yuan Y, Granger HJ, et al. Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am J Physiol 1992; 263: H641.
- Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262: H611.
- Beckman JS, Beckman TW, et al. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620.
- Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors FASEB J 1989; 3: 2007–220018.
- Ignarro LJ, Byrns RE, Wood KS. Endothelium-dependent modulation of cyclic GMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ Res 1987; 60: 82–92.
- Tomeo AC, Egan RW, Durán WN. Priming interactions between platelet activating factor and histamine in the in vivo microcirculation. FASEB J 1991; 5: 2850–2859.
- Colden-Stanfield M, Schilling WP, et al. Bradykinin-induced increases with cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Circ Res 1987; 61: 632–640.
- Murry MA, Heistad DD, Mayhan WG. Role of protein kinase C in bradykinin-induced increases in microvascular permeability. Circ Res 1991; 68: 1340–1348.
- Rosenberg RD, Rosenberg JS. Natural anticoagulant mechanisms. J Clin Invest 1984; 74: 1–5.
- Esmon CT, Owen WG. Identification of an endothelial cofactor for thrombin-catalyzed activation of protein. Proc Soc Natl Acad Sci USA 1981; 78: 2249–2252.
- Pober JS, Cotrain RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427–451.
- Zimmerman GA, McIntyre TM, Prescott SM. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J Clin Invest 1985; 76: 2235–2246.
- Zimmerman GA, McIntyre TM. Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mol MAC/LAF-1, GP150, 95) glycoprotein-dependent and independent mechanisms. J Clin Invest 1988; 81: 531–537.
- McEver RP, Bechstead JH, et al. GMP-140, a platelet granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989; 84: 92–99.
- Kubes P, Kvietys PR, Granger DN. Ischemia-reperfusion injury. In: NA Mortillaro, AE Taylor, eds. The pathophysiology of the microcirculation. Boca Raton, FL: CRC Press, 1994.
- Smith JK, Grisham GB, et al. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol 1989; 256: H789–H793.
- Korthius RJ, Grisham GB, Granger DN. Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 1989; 24454: H283–H287.
- Belkin M, LaMorte WL, et al. The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg 1989; 10: 14–19.
- Breitbart GB, Dillon PK, et al. Leukopenia reduces microvascular clearance of macromolecules in is-chemia-reperfusion injury. Curr Surg 1990; 47: 8–12.
- Ferrante RJ, Hobson RW II, Miyasaka M, Granger DN, Durán WN. Inhibition of white blood cell adhesion at reperfusion decreases tissue damage in postischemic striated muscle. J Vasc Surg 1996; 24: 187–193.
- Ley K, Gaehtgens P, et al. Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 1991; 77: 2553.
- Lawrence MB, Springer TA. Leukocytes roll on a selection at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991; 65: 859.
- Kubes P, Suzuki M, Granger DN. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol 1990; 259: G859.
- Yasuhara H, Hobson RW II, et al. A new model for studying ischemia-reperfusion injury in the hamster cheek pouch. Am J Physiol 1991; 261: H1626–1629.
- Hernandez LA, Grisham MB, et al. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987; 253: H699.
- Kubes P, Suzuki M, Granger DN. Platelet-activating factor-induced microvascular dysfunction: The role of adherent leukocytes. Am J Physiol 1990; 258: G158.
- Carden DL, Smith JK, Korthuis RJ. Oxidant-mediated, CD-18-dependent microvascular dysfunction induced by complement-activated granulocytes. Am J Physiol 1991; 260: H1144.
- Mangino MJ, Anderson CB, et al. Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am J Physiol 1989; 257: G299.
-
Zimmerman BJ,
Guillory DJ,
et al.
Role of leukotriene B4 in granulocyte infiltration into the postischemic feline intestine.
Gastroenterology
1990;
99:
1.
10.1016/0016-5085(90)91162-Y Google Scholar
- Goldman G, Welbourn R, et al. Ischemia induced neutrophil activation and diapedesis are lipoxygenase dependent. Surgery 1990; 107: 428.
- Durán WN, Suval WD, et al. Microcirculatory dysfunction in the pathophysiology of skeletal muscle ischemia. In: FJ Veith, RW Hobson, et al, eds. Vascular Surgery: Principles and Practices. New York: McGraw-Hill, 1993: 388–396.
- Filep J, Herman F, et al. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Cmmun 1989; 158: 353.
- Blaisdell FW. The reperfusion syndrome. Microcirc Endothel Lymph 1989; 5: 127.
- Paul J, Bekker AY, Durán WN. Calcium entry blockade prevents leakage of macromolecules induced by is-chemia-reperfusion in skeletal muscle. Circ Res 1990; 66: 1636.
- Blebea J, Cambria RA, et al. Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg 1990; 12: 657.
- Belkin M, Wright JG, Hobson RW II. Iloprost infusion decreases skeletal muscle injury after ischemia- reperfusion. J Vasc Surg 1990; 11: 77.
- Simpson PJ, Michelson J, et al. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart. Circ Res 1990; 60: 666.
- Cronenwett JL, Lee KR et al. The effect of ischemia-reperfusion derived oxygen free radicals on skeletal muscle calcium metabolism. Microcirc Endothelium Lymphatics 1989; 5: 171.
- Dillon PK, Ritter AB, Durán WN. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: Dose-related relations and pathways of action. Circ Res. 1988; 62: 722.
- Dillon PK, Durán WN. Effect of platelet-activating factor on microvascular permselectivity: Dose-response relations and pathways of action in the hamster check pouch microcirculation. Circ Res 1988; 62: 732.
- Durán WN, Dillon PK. Acute microcirculatory effects of platelet-activating factor. J Lipid Mediat 1990; 2: S215.
- Dillon PK, FitzPatrick MF, et al. Effect of platelet-activating factor on leukocyte adhesion to microvascular adhesion. Inflammation 1988; 12: 563–573.
- Ramírez, M.M., Quardt, S.M., et al. Platelet-activating factor modulates microvascular permeability through nitric oxide synthesis. Microvasc Res 1995; 50: 223–234.
- Tomeo AC, Durán WN. Resistance and exchange mi-crovessels are modulated by different PAF receptors. Am J Physiol 1991; 261: H1648.
- Lewis MS, Whatley RE, et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045.
- Zimmerman GA, McIntyre TM, et al. Endothelial cell-association platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529.
- Lorant DE, Patel KP, et al. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991; 115: 223.
- Kubes P, Ibbotson G, et al. Role of platelet-activating factor in ischemia-reperfusion-induced leukocyte adherence. Am J Physiol 1990; 259: G300.
- Durán, W.N., Milazzo, V.J., et al. Platelet-activating factor modulates leukocyte adhesion to endothelium in ischemia-reperfusion injury. Microvasc Res 1996 51: 108–115.
- Yoshida N, Anderson DC, et al. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol 1992; 252: H1891.
- Simpson PJ, Todd RF, et al. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (Anti Mo1, Anti-CD116) that inhibits leukocyte adhesion. J Clin Invest 1981; 68: 1394–1403.
- Hobson RW II, Wright JG, et al. Heparinization reduces endothelial permeability and hydrogenion accumulation in a canine skeletal muscle ischemia-reperfusion model. J Vasc Surg 1988; 7 (4): 585–591.
- Sternbergh WC III, Makhoul RG, Adelman B. Heparin prevents postischemic endothelial cell dysfunction by a mechanism independent of its anticoagulant activity. J Vasc Surg 1993; 17: 318–3227.
- Sternbergh WC III, Makhoul RG, Adelman B. Nitric-oxide mediated endothelial-dependent vasodilation is selectively attenuated in the postischemic extremity. Surg 1993; 114: 960–967.
- Sternbergh WC III, Sobel M, Makhoul RG. Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction. J Vasc Surg 1995; 21: 477–483.
- Belkin M, Wright JG, Hobson RW II. Iloprost infusion decreases skeletal muscle ischemia-reperfusion injury. J Vasc Surg 1990; 11: 77–83.
- Quiñones-Baldrich WJ. Surgical management of acute limb ischemia: intraoperative considerations. Semin Vasc Surg 1992; 5: 42–51.
- Ouriel K, Shortell CK, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021–1030.
- Breitbart GB, Dillon PK, et al. Dexamethasone attenuates microvascular ischemia-reperfusion injury in the rat cremaster muscle. Microvasc Res 1989; 38: 155–163.
- Wright JG, Fox D, et al. Rate of reperfusion blood flow modulates reperfusion injury in skeletal muscle. J Surg Res 1988; 44: 754–763.
- Anderson RJ, Cambria R, et al. Sustained benefit of temporary limited reperfusion in skeletal muscle following ischemia. J Surg Res 1990; 49: 271–275.
- Beyersdorf F, Mitrev Z, et al. Controlled limb reperfusion as a new surgical technique to reduce postischemic syndrome. J Thorac Cardiovasc Surg 1993; 106: 378–380.
- Beyersdorf F. Protection of the ischemic skeletal muscle. Thorac Cardiovasc Surg 1991; 39: 19–28.
- Wright JG, Araki CT, et al. Postischemic hypothermia diminishes skeletal muscle reperfusion edema. J Surg Res 1989; 47: 389–396.
- Rutherford RB. Acute limb ischemia: clinical assessment and standards for reporting. Semin Vasc Surg 1992; 5: 4–10.
- Furchgott, RF, Zawadski, JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376.
- Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol 1990; 30: 535–560.
- Pollock JP, Forstermann U, et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88: 10480–10484.
- Shesely EG, Maeda N, et al. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc Soc Natl Acad Sci (USA) 1996; 93: 13176–13181.
- Ialenti A, Ianaro A, et al. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211: 177–182.
- Ramirez MM, Kim DD, Durán, W.N. Protein kinase C modulates microvascular permeability through nitric oxide synthase. Am J Physiol 1996; 271: H1702–H1705.
- Yuan Y, Granger HJ, et al. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cascade. Am J Physiol 1993; 264: H1734–H1739.
- Wu, H.M., Yuan, Y., et al. Role of phospholipase C, Protein kinase C, and calcium in VEGF-induced venular hyperpermeability. Am J Physiol 1999; 276: H535–H542.
- Kurose I, Kubes P, et al. Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage. Circ Res 1993; 73: 164–171.
- Kurose I, Wolf R, et al. Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ Res 1995; 76: 30–39.
- Kurose I, Wolf R, et al. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 1994; 74: 376–382.
- Goetz RM, Thatte HS, et al. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1999; 96: 2788–2793.
- Michel T, Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 1997; 100: 2146–2152.
- Michel T, Li GK, Busconi I. Phosphorylation and subcel-lular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993; 90: 6252–6256.
- Hood JD, Meininger CJ, et al. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274: H1054–H1058.
- Huang, Q, Yuan, Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol 1997; 273: H2442–H2451.
- Mayhan WG. Role of nitric oxide in leukotriene C4-induced increases in microvascular transport. Am J Physiol 1993; 265: H409–H414.
- Mayhan WG. Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 1994; 266: H2369–H2373.
- Mayhan WG. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 1999; 276 (5 Pt 1): C1148–53.
- Murray, MD, Heistad, DD, Mayhan, WG. Role of protein kinase C in bradykinin-induced increase in microvascular permeability. Circ Res 1991; 68: 1340–1348.
- He P, Zeng M, Curry FE. cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i. Am J Physiol 1998; 274: H1865–H1874.
- Huxley VH, Tucker VL, et al. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ Res 1987; 60: 304–307.
- Meyer DJ, Huxley VH. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ Res 1992; 70: 382–391.
- Kubes P. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP. Am J Physiol 1993; 265: H1909–H1915.
- Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519–14522.
- Lamas S, Marsden PA, et al. Endothelial nitric oxide: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348–6352.
- Nishida K, Harrison DG, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90: 2092–2096.
- Schmidt HHHW, Murad F. Purification and characterization of a human NO synthase. Biochem Biophys Res Comm 1991; 181: 1372–1377.
- Sessa WC, Harrison JK, et al. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 1992; 267: 15274–15276.
- Venema RC, Nishida K, et al. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1994; 1218: 413–420.
- Garcia-Cardena G, Fan R, et al. Endothelial cell nitric oxide is regulated by tyrosine phosphorylation andinter-acts with caveolin-1. J Biol Chem 1996; 271: 27237–27240.
- Garcia-Cardena G, Oh P, et al. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide sigaling. Proc Natl Soc Sci 1996; 93: 6448–64553.
- Ohara Y, Sayegh HS, et al. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 1995; 25: 415–420.
- Corson MA, James NL, et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 1996; 79 (5): 984–991.
- Dimmeler S, Fleming I, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601–605.
- Fulton D, Gratton JP, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597–601.
- Gallis B, Corthals GL, et al. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 1999; 274: 30101–30108.
- Kim D, Durán WN. Platelet-activating factor stimulates protein tyrosine kinase in the hamster cheek pouch microcirculation. Am J Physiol 1995; 268: H399–H403.
- Kim DD, Ramirez MM, Durán WN. Platelet-activating factor modulates microvascular dynamics through phospholipase C in the hamster cheek pouch. Microvasc Res; 59: 7–13.
- Lal BK, Varma S, et al. VEGF increases permeability of endothelial cell monolayers by activation of PKB/akt, endothelial nitric oxide synthase and MAP kinase pathways. Microvasc Res 2001; 62: 252–262.
- Varma S, Breslin JW, Lal BK, et al. p42/44 MAP kinase regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc Res 2002; 63: 172–178.
- Durán WN, Seyama A, et al. Stimulation of NO production and of eNOS phosphorylation in the microcirculation in vivo. Microvasc Res 2000; 60: 104–111.
- Noel AA, Hobson RW II, Durán WN. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury. Microvasc Res 52: 210.220, 1996.
- Kurose I, Anderson DC, et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994; 74: 336–343.
- Takenaka H, Oshiro H, et al. Microvascular transport is associated with tumor necrosis factor plasma levels and protein synthesis in postischemic muscle. Am J Physiol 1998; 274: H1914–H1919.
- Dvorak HF, Nagy JA, et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97–132.
-
Kraft A,
Weindel K,
et al.
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Cancer
1999;
85:
178–187.
10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7 CAS PubMed Web of Science® Google Scholar
- Kranz A, Rau C, et al. Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance. J Mol Cell Cardiol 2000; 32: 65–72.
- Isner JM. Angiogenesis: a “breakthrough” technology in cardiovascular medicine. J Invasive Cardiol 2000; 12 Suppl A: 14.-17A.
- Isner JM. Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. Adv Drug Deliv Rev 1998; 30 (1–3): 185–197.
- Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther 2000; 7: 451–457.
- Yang HT, Yan Z, et al. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production. Am J Physiol Heart Circ Physiol 2001; 280: H1097–1104.
- Hopkins SP, Bulgrin JP, et al. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia. J Vasc Surg 1998; 27 (5): 886–894.
- Thurston G, Suri C, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286 (5449): 2511–2514.
- Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999 May 1; 13 (9): 1055–1066.
- Papapetropoulos A, Garcia-Cardena G, et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 1999; 79 (2): 213–223.
- Ihnken K, Wildhirt S, et al. Skeletal muscle reperfusion injury: reversal by controlled limb reperfusion: a case report. Vasc Surg 2001; 35: 149–155.
- Kobayashi I, Kim D, et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. Am J Physiol 1994; 266: H1214–H1220.
